Bansal Wire And Emcure: Allotment of shares for Bansal Wire Industries IPO will be done today (Monday, July 8). Investors who applied for Bansal Wire IPO can check the allotment status on the registrar's portal Caffin Technologies Limited. Allotment of Emcure Pharmaceuticals IPO can also happen today. Bidding for this ended on Friday. As per the 'T+3' listing rule, share allotment is likely to happen on July 8, 2024 i.e. today. Its registrar is Link Intime India.

Bansal Wire Industries

The IPO of the steel wire manufacturer opened for subscription on Wednesday, July 3 and closed on Friday, July 5. The issue was subscribed 13.64 times in the retail category, 146.05 times in QIB and 51.46 times in the NII category. The overall subscription status stood at 59.57 times.

How to check IPO allotment status

To check the status of IPO allotment, you have to go to . Here you will find five links, clicking on any of which will check the allotment status.

After clicking on the link, you have to select Bansal Wire from the “Select IPO” drop-down menu. Enter the application number, demat account or PAN here. Then enter the captcha code and press “Submit”.

When the shares are allotted, they will be credited to their demat account on the same day. Those who did not get shares will get a refund. For those who did not get shares, the refund process will start from July 9. Share listing will take place on July 10.

Listing of shares may increase by 29.69%

The GMP (grey market price) of Bansal Wire's IPO today is +76. That is, the shares can be listed at Rs 332, which is 29.69 percent higher than the IPO price of Rs 256. The price band of this issue was fixed at Rs 243-256. The company wants to raise Rs 745 crore through this IPO. For this, the company is issuing 29,101,562 shares for the entire Rs 745 crore. The existing investors of the company are not selling a single share through the offer for sale.

Don't forget to follow the WhatsApp channel of Read.Com.

Contact to :

Privacy Agreement

Copyright © boyuanhulian 2020 - 2023. All Right Reserved.